Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21347593 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Hybrid Sirolimus-eluting Versus Everolimus-eluting Stents for Total Coronary Occlusions
Conditions: Coronary Artery Disease;   Coronary Disease;   Coronary Stenosis
Intervention: Device: Hybrid sirolimus- and everolimus-eluting stents (ORSIRO, XIENCE PRIME)

Indicates status has not been verified in more than two years